Insulin

Affordability Halal Products Sanofi Treatment Compliance Clinical Trials Tirzepatide Hypoglycemia Halal Insulin Inhaled Insulin Rapid-acting Insulin Analogues Insulin Products Medical Costs

7 ARTICLES

last wk.

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

The authorization adds a needle-free, ultra‑rapid mealtime insulin for young patients with required lung‑function checks and a company affordability program.